Desmopressin Acetate Tablets — Class II drug recall D-0849-2020
Terminated recall by American Health Packaging, reported 2020-02-26, distributed nationwide. GMP Deviations: Product bottle may be absent of desiccant.
| Recall number | D-0849-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | American Health Packaging, Columbus, OH, United States |
| Recall initiated | 2020-02-07 |
| Classified | 2020-02-18 |
| Reported by FDA | 2020-02-26 |
| Terminated | 2022-08-04 |
| Distributed | Nationwide (US) |
| Quantity | 3,720 cartons |
| Reason classes | cgmp |
| NDC | 68084-0604-11, 68084-0604-21 |
| Lot numbers | 180510, 181912 |
| Expiration dates | 2020-03-31, 2020-04-30 |
Product
Desmopressin Acetate Tablets, 0.2 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged and distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 68084-604-21; NDC Unit Dose 68084-604-11
Reason for recall
GMP Deviations: Product bottle may be absent of desiccant.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0849-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.